After 3 days, we observed that all five cancer cell lines that were co-cultured with UCP1, PPARGC1A or PRDM16 CRISPRa-treated human adipocytes showed significantly lower cell numbers than cancer cells co-cultured with dCas9–VP64-treated adipocytes (Fig. 1b). The gene discussed is PPARGC1A; the disease is cancer.